SCYNEXIS, Inc. reported the following changes to its executive leadership team: Dr. Taglietti, after more than seven years leading the company, announced plans to retire at the end of the year. He will leave his position as SCYNEXIS' President and Chief Executive Officer and will step down from the Board of Directors on December 31, 2022. David Angulo, M.D., who has served as Chief Medical Officer for the past seven years, will become President and Chief Executive Officer of SCYNEXIS and join the Board of Directors, effective January 1, 2023.

With the shift in corporate priorities, the role of Chief Commercial Officer will be eliminated, and Christine Coyne, who has served in this leadership role for more than a year, will transition from the Company to pursue other opportunities.